Ross A Baker

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. ncbi Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis
    Ross A Baker
    Bristol Myers Squibb, Princeton, NJ, USA
    Psychopharmacol Bull 42:11-31. 2009
  2. doi Impact of oral antipsychotic medication adherence on healthcare resource utilization among schizophrenia patients with medicare coverage
    Steve Offord
    Otsuka America Pharmaceutical, Inc, Princeton, NJ, USA
    Community Ment Health J 49:625-9. 2013
  3. doi Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral
    Steve Offord
    Otsuka America Pharmaceutical, Inc, Princeton, NJ, USA
    J Med Econ 16:231-9. 2013
  4. doi Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia
    W Wolfgang Fleischhacker
    Department of Psychiatry and Psychotherapy, Division of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    Int Clin Psychopharmacol 28:171-6. 2013
  5. ncbi Adjunctive aripiprazole for depression: predictive value of early assessment
    David J Muzina
    Medco Health Solutions, Inc, Plainsboro, NJ, USA
    Am J Manag Care 17:793-801. 2011

Detail Information

Publications5

  1. ncbi Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis
    Ross A Baker
    Bristol Myers Squibb, Princeton, NJ, USA
    Psychopharmacol Bull 42:11-31. 2009
    ..The present study evaluated the potential association between atypical antipsychotics or haloperidol and diabetes using data from the FDA AERS database...
  2. doi Impact of oral antipsychotic medication adherence on healthcare resource utilization among schizophrenia patients with medicare coverage
    Steve Offord
    Otsuka America Pharmaceutical, Inc, Princeton, NJ, USA
    Community Ment Health J 49:625-9. 2013
    ..Low adherent Medicare insured patients with schizophrenia require significantly more inpatient care and represent a patient population in which effective interventions are needed to improve disease management...
  3. doi Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral
    Steve Offord
    Otsuka America Pharmaceutical, Inc, Princeton, NJ, USA
    J Med Econ 16:231-9. 2013
    ..To compare hospitalizations and incidence of relapses among patients with schizophrenia initiating long-acting injectable (LAI) antipsychotics vs oral antipsychotics...
  4. doi Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia
    W Wolfgang Fleischhacker
    Department of Psychiatry and Psychotherapy, Division of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
    Int Clin Psychopharmacol 28:171-6. 2013
    ..There were no unexpected changes in weight or shifts in fasting metabolic parameters across all study phases. ARI-OM had a safety and tolerability profile comparable with oral aripiprazole in maintenance treatment of schizophrenia...
  5. ncbi Adjunctive aripiprazole for depression: predictive value of early assessment
    David J Muzina
    Medco Health Solutions, Inc, Plainsboro, NJ, USA
    Am J Manag Care 17:793-801. 2011
    ..To determine whether early symptom improvement with adjunctive aripiprazole in major depressive disorder (MDD) predicts overall symptom remission...